Good morning, and welcome to the Equillium Virtual Investor Event. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Equillium website ...

Scientists may have found a completely new way to treat depression by targeting inflammation instead of brain chemistry.

A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an ...

Gaseous pollutants from traffic sources add to evidence for particulate-matter harms ...

Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details ...

Every year, roughly 6.5 million Americans struggle with chronic wounds that refuse to close. The majority are over 65. Their ...

Data published in the Journal of the American College of Cardiology Represents first peer-reviewed publication of clinical data demonstrating ...

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical ...

The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.

Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...